Á lódáil...
Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells
BACKGROUND: Glioblastoma (GBM) is the most common primary brain malignancy and confers a dismal prognosis. GBMs harbor glioblastoma-initiating cells (GICs) that drive tumorigenesis and contribute to therapeutic resistance and tumor recurrence. Consequently, there is a strong rationale to target this...
Na minha lista:
| Foilsithe in: | Mol Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
BioMed Central
2015
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4546247/ https://ncbi.nlm.nih.gov/pubmed/26292663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-015-0432-z |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|